Albert David Ltd (ALBERTDAVD) AI Stock Analysis

• Market Cap: ₹3.77B
• Dividend Yield: 0.66%
• Average Volume (3M): 210.00
• Price to Earnings (P/E): 6.9
• Beta (1Y): 1.07
• Revenue Growth: -13.51%
• EPS Growth: -122.00%
• Country: IN
• Employees: 1,497
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): 26.82
• Shares Outstanding: 5,707,162
• 10 Day Avg. Volume: 184
• 30 Day Avg. Volume: 210
• PEG Ratio: -0.36
• Price to Book (P/B): 1.21
• Price to Sales (P/S): 1.37
• P/FCF Ratio: -10.94
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 51 Neutral
• Price Target: ₹664.00 ▼(-15.78% Downside)
• Action: Reiterated Date: 11/25/25
• Date: Action: Reiterated 11/25/25

Albert David Ltd's overall stock score is primarily impacted by its strong balance sheet, which is overshadowed by declining financial performance and bearish technical indicators. The negative P/E ratio and low dividend yield further weigh on the valuation.

Positive Factors

Balance sheet strength

Low leverage and robust equity provide durable financial stability. This reduces bankruptcy and refinancing risk, lets management fund operations or targeted investments during downturns, and preserves strategic optionality to support recovery over the next several months.

Gross profit margin

A strong gross margin signals manufacturing efficiency or pricing power in formulations. That structural margin buffer helps absorb revenue volatility, sustain core profitability, and provides scope to restore net margins if revenue stabilizes or operational improvements continue.

Return on equity track record

Historically high ROE indicates efficient capital allocation and profitable use of equity. Even with a recent decline, this track record suggests management has delivered value before and retains practices and assets that can underwrite future returns if top-line and cash generation recover.

Negative Factors

Revenue decline

Sustained revenue contraction erodes scale economics and market positioning. Over a multi-month horizon, falling sales constrain margin recovery, reduce bargaining power with suppliers and distributors, and limit the ability to fund R&D, marketing, or capex needed to regain growth.

Negative operating and free cash flow

Negative operating and free cash flows are a structural concern. They limit the company's capacity to self-fund working capital and investments, may force external financing or asset sales, and reduce resilience to continued revenue weakness over the coming months.

Sharp EPS deterioration

A steep EPS decline indicates acute profitability pressure, whether from mix, costs, or one-offs. This depletes retained earnings and weakens the internal funding base, making it harder to execute strategic initiatives or restore dividends without material operational improvement.

Albert David Ltd Business Overview & Revenue Model

Company Description

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries. The company was incorporated in 1938 and is headquartered in Kolkata, India.

How the Company Makes Money

The company makes money primarily by selling pharmaceutical formulations. Revenue is generated through (1) domestic sales to healthcare channels (such as distributors/stockists, pharmacies, and institutional customers) for branded and/or generic formulations, and (2) export sales of formulations to overseas customers/partners where applicable. Earnings are driven by product mix, volumes, pricing, tender/institutional orders (if any), and the scale and efficiency of its manufacturing and supply chain. Specific details on customer concentration, named partnerships, contract manufacturing arrangements, or the exact split between domestic and export revenues are null.

Albert David Ltd Financial Statement Overview

Summary

Albert David Ltd shows a strong balance sheet with low leverage and solid equity, but faces challenges with declining revenue, profitability, and negative cash flows. These issues need addressing for sustainable growth.

Income Statement

Albert David Ltd has shown a mixed performance in terms of revenue and profitability. The gross profit margin is strong, indicating effective cost management, but the net profit margin has declined significantly in the latest year, reflecting a decrease in profitability. Revenue has shown fluctuations, with a notable decline in the most recent year, which is a concern for growth prospects.

Balance Sheet

The company's balance sheet reflects solid equity and a low level of debt, which is a positive indicator of financial stability. The equity ratio is robust, and the company has maintained a strong return on equity, although it has decreased in the latest year. The low debt-to-equity ratio limits financial risk.

Cash Flow

Cash flow from operations has turned negative in the latest year, which is a significant drawback. Free cash flow also fell into negative territory, indicating potential liquidity issues. In previous years, cash flow metrics were healthier, but the recent downturn in free cash flow growth rate raises concerns about the company's ability to generate cash.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	3.16B	3.46B	3.60B	3.42B	3.12B	2.46B
Gross Profit	1.75B	2.29B	2.32B	2.18B	1.95B	1.58B
EBITDA	-359.98M	30.26M	1.05B	598.68M	567.76M	364.59M
Net Income	-150.80M	172.01M	754.20M	361.75M	352.58M	221.43M
Balance Sheet
Total Assets	5.33B	5.11B	4.98B	4.23B	4.03B	3.41B
Cash, Cash Equivalents and Short-Term Investments	2.84B	2.44B	2.85B	2.03B	1.75B	1.49B
Total Debt	414.14M	123.17M	33.24M	53.18M	56.62M	16.19M
Total Liabilities	1.39B	1.19B	1.15B	1.12B	1.23B	970.20M
Stockholders Equity	3.94B	3.92B	3.83B	3.12B	2.79B	2.44B
Cash Flow
Free Cash Flow	-271.21M	-432.92M	346.28M	52.78M	292.83M	349.79M
Operating Cash Flow	-208.45M	-284.36M	455.02M	105.15M	403.65M	366.11M
Investing Cash Flow	-46.97M	233.01M	-332.48M	-49.95M	-396.97M	-366.84M
Financing Cash Flow	248.82M	1.10M	-82.70M	-63.62M	-12.59M	-17.05M

Albert David Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 788.40
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ALBERTDAVD, the sentiment is Negative. The current price of 788.4 is above the 20-day moving average (MA) of 686.73, above the 50-day MA of 700.57, and below the 200-day MA of 789.48, indicating a bearish trend. The MACD of -11.98 indicates Positive momentum. The RSI at 38.85 is Neutral, neither overbought nor oversold. The STOCH value of 62.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ALBERTDAVD.

Albert David Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ZIMLAB	63 Neutral	₹3.34B	19.99	―	―	-5.82%	-59.22%
LYKALABS	54 Neutral	₹1.97B	-338,564.26	―	―	4.04%	-35.02%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ALBERTDAVD	51 Neutral	₹3.77B	6.87	―	0.66%	-13.51%	-122.00%
VIKASLIFE	48 Neutral	₹2.40B	-32.50	―	―	9.42%	-12220.00%
BROOKS	46 Neutral	₹1.55B	10.71	―	―	18.67%	―
NECLIFE	46 Neutral	₹2.45B	7.63	―	―	-30.27%	-3470.06%

Albert David Ltd Corporate Events

Albert David Publishes Notice on Re-Lodgement of 300 Physical Shares

Albert David Ltd has disclosed that it received a request from investor Bharat Kumar N Jain for transfer of 300 physical equity shares into his name, relating to securities previously purchased but not transferred. In line with SEBI guidelines on transfer of physical securities, the company has invited any counterclaims from potential claimants within 30 days, after which it will proceed with the transfer if no valid objections are received.

To comply with regulatory requirements and ensure transparency, Albert David has published details of this re-lodgement of share transfer in the March 13, 2026 editions of Financial Express and Aajkal. The move underscores the company’s adherence to SEBI’s investor protection framework and formalizes the process for resolving ownership of legacy physical share certificates before completing the transfer to the requesting investor.